Clinical Trial Update: Bupropion for Hospital-Based Smoking Cessation [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating bupropion for hospital-based smoking cessation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nicotine Dependence
• Tobacco Use Disorder

Drugs mentioned

• bupropion (bupropion)

Snippet

Sponsor: University of California, San Francisco | Conditions: Smoking | Phase 3 | Status: COMPLETED